Novel Therapeutic Protein
T-sphaera
Next Generation
Immunotherapy
T-sphaera Drug Conjugate
Company

Cellemedy

A biotechnology company dedicated to developing next
generation therapeutic proteins with the aim of replacing
the conventional antibody treatments.

SCIENCE

SCIENCE

Cellemedy’s Innovative Technologies
for Better Human Health

Pipeline

Oncology

TSIT

Next Generation Immunotherapy

TSDC

T-sphaera Drug Conjugate

Next Generation Immunotherapy
T-sphaera Drug Conjugate
Pipeline Oncology

Notice

more +

Press Release

more +